Exogenous Glucagon-like Peptide-1 Acts in Sites Supplied by the Cranial Mesenteric Artery to Reduce Meal Size and Prolong the Intermeal Interval in Rats

Overview

Journal Appetite

Specialties Nutritional Sciences
Social Sciences

Date 2015 Oct 4

PMID 26431682

Citations 10

Authors

Kasey E Williams

Martha C Washington

Tanisha Johnson-Rouse

Ruth E Johnson

Corren Freeman

Chris Reed

John Heath

Ayman I Sayegh

Affiliations

Soon will be listed here.

Abstract

Three experiments were done to better assess the gastrointestinal (GI) site(s) of action of GLP-1 on food intake in rats. First, near-spontaneous nocturnal chow meal size (MS), intermeal intervals (IMI) length and satiety ratios (SR = MS/IMI) were measured after infusion of saline, 0.025 or 0.5 nmol/kg GLP-1 into the celiac artery (CA, supplying the stomach and upper duodenum), cranial mesenteric artery (CMA, supplying small and all of the large intestine except the rectum), femoral artery (FA, control) or portal vein (PV, control). Second, infusion of 0.5 nmol/kg GLP-1 was tested after pretreatment with the GLP-1 receptor (GLP-1R) antagonist exendin-4(3-39) via the same routes. Third, the regional distribution of GLP-1R in the rat GI tract was determined using rtPCR. CA, CMA and FA GLP-1 reduced first MS relative to saline, with the CMA route more effective than the others. Only CMA GLP-1 prolonged the IMI. None of the infusions affected second MS or later eating. CA and CMA GLP-1 increased the SR, with the CMA route more effective than the CA route. CMA exendin-4 (3-39) infusion reduced the effect of CMA GLP-1. Finally GLP-1R expression was found throughout the GI tract. The results suggest that exogenous GLP-1 acts in multiple GI sites to reduce feeding under our conditions and that GLP-1R in the area supplied by the CMA, i.e., the small and part of the large intestine, plays the leading role.

Citing Articles

An oral gavage of lysine elicited early satiation while gavages of lysine, leucine, or isoleucine prolonged satiety in pigs.

Muller M, Xu C, Navarro M, Elias-Masiques N, Tilbrook A, van Barneveld R J Anim Sci. 2022; 100(12).

PMID: 36315475 PMC: 9746803. DOI: 10.1093/jas/skac361.

Endogenous Protective Factors and Potential Therapeutic Agents for Diabetes-Associated Atherosclerosis.

Wang C, Chen J, Wang P, Qing S, Li W, Lu J Front Endocrinol (Lausanne). 2022; 13:821028.

PMID: 35557850 PMC: 9086429. DOI: 10.3389/fendo.2022.821028.

Non-sulfated cholecystokinin-8 reduces meal size and prolongs the intermeal interval in male Sprague Dawley rats.

Dafalla A, Mhalhal T, Washington M, Spann S, Reguero A, Morgan A Neuropeptides. 2018; 73:57-65.

PMID: 30470455 PMC: 6613573. DOI: 10.1016/j.npep.2018.11.003.

Acidosis potentiates endothelium-dependent vasorelaxation and gap junction communication in the superior mesenteric artery.

Mohanty I, Parija S, Suklabaidya S, Rattan S Eur J Pharmacol. 2018; 827:22-31.

PMID: 29524386 PMC: 5882507. DOI: 10.1016/j.ejphar.2018.03.004.

Peptide Tyrosine Tyrosine 3-36 Reduces Meal Size and Activates the Enteric Neurons in Male Sprague-Dawley Rats.

Newman K, Mhalhal T, Washington M, Heath J, Sayegh A Dig Dis Sci. 2017; 62(12):3350-3358.

PMID: 29030744 DOI: 10.1007/s10620-017-4788-3.

References

Nakagawa A, Satake H, Nakabayashi H, Nishizawa M, Furuya K, Nakano S . Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci. 2004; 110(1):36-43. DOI: 10.1016/j.autneu.2003.11.001. View

Gulley S, Sharma S, Mansour M, Sullivan C, Moran T, Sayegh A . Strain differences in myenteric neuron number and CCK1 receptor mRNA expression may account for differences in CCK induced c-Fos activation. Brain Res. 2005; 1058(1-2):109-19. DOI: 10.1016/j.brainres.2005.07.074. View

Gamse R . Capsaicin and nociception in the rat and mouse. Possible role of substance P. Naunyn Schmiedebergs Arch Pharmacol. 1982; 320(3):205-16. DOI: 10.1007/BF00510129. View

Sayegh A . The role of cholecystokinin receptors in the short-term control of food intake. Prog Mol Biol Transl Sci. 2013; 114:277-316. DOI: 10.1016/B978-0-12-386933-3.00008-X. View

Sayegh A, Washington M, Johnson R, Johnson-Rouse T, Freeman C, Harrison A . Celiac and the cranial mesenteric arteries supply gastrointestinal sites that regulate meal size and intermeal interval length via cholecystokinin-58 in male rats. Horm Behav. 2014; 67:48-53. DOI: 10.1016/j.yhbeh.2014.11.011. View

Zhang J, Ritter R . Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms. Am J Physiol Regul Integr Comp Physiol. 2011; 302(2):R264-73. PMC: 3349390. DOI: 10.1152/ajpregu.00114.2011. View

Washington M, Aglan A, Sayegh A . The stomach and/or upper duodenum contain sites of action that control meal size and intermeal interval length by exogenous rat gastrin releasing peptide. Peptides. 2014; 55:41-6. DOI: 10.1016/j.peptides.2014.02.004. View

Arnold M, Dai Y, Tso P, Langhans W . Meal-contingent intestinal lymph sampling from awake, unrestrained rats. Am J Physiol Regul Integr Comp Physiol. 2012; 302(12):R1365-71. DOI: 10.1152/ajpregu.00497.2011. View

Korner J, Bessler M, Inabnet W, Taveras C, Holst J . Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007; 3(6):597-601. PMC: 2134840. DOI: 10.1016/j.soard.2007.08.004. View

10.

Hayes M, Kanoski S, De Jonghe B, Leichner T, Alhadeff A, Fortin S . The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1. Am J Physiol Regul Integr Comp Physiol. 2011; 301(5):R1479-85. PMC: 3213943. DOI: 10.1152/ajpregu.00356.2011. View

11.

Ruttimann E, Arnold M, Geary N, Langhans W . GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats. Physiol Behav. 2010; 100(4):291-6. DOI: 10.1016/j.physbeh.2010.02.022. View

12.

Amato A, Baldassano S, Liotta R, Serio R, Mule F . Exogenous glucagon-like peptide 1 reduces contractions in human colon circular muscle. J Endocrinol. 2014; 221(1):29-37. DOI: 10.1530/JOE-13-0525. View

13.

Asarian L, Abegg K, Geary N, Schiesser M, Lutz T, Bueter M . Estradiol increases body weight loss and gut-peptide satiation after Roux-en-Y gastric bypass in ovariectomized rats. Gastroenterology. 2012; 143(2):325-7.e2. DOI: 10.1053/j.gastro.2012.05.008. View

14.

Baggio L, Huang Q, Brown T, Drucker D . A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes. 2004; 53(9):2492-500. DOI: 10.2337/diabetes.53.9.2492. View

15.

Deacon C, Holst J . Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety. Expert Opin Pharmacother. 2013; 14(15):2047-58. DOI: 10.1517/14656566.2013.824966. View

16.

Eissele R, Goke R, Willemer S, Harthus H, Vermeer H, Arnold R . Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest. 1992; 22(4):283-91. DOI: 10.1111/j.1365-2362.1992.tb01464.x. View

17.

Kinzig K, DAlessio D, Seeley R . The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci. 2002; 22(23):10470-6. PMC: 6758755. View

18.

Sayegh A . The role of bombesin and bombesin-related peptides in the short-term control of food intake. Prog Mol Biol Transl Sci. 2013; 114:343-70. DOI: 10.1016/B978-0-12-386933-3.00010-8. View

19.

Lateef D, Washington M, Raboin S, Roberson A, Mansour M, Williams C . Duodenal myotomy blocks reduction of meal size and prolongation of intermeal interval by cholecystokinin. Physiol Behav. 2011; 105(3):829-34. DOI: 10.1016/j.physbeh.2011.10.018. View

20.

Ruttimann E, Arnold M, Hillebrand J, Geary N, Langhans W . Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology. 2008; 150(3):1174-81. PMC: 2654737. DOI: 10.1210/en.2008-1221. View